Biological therapies need definitive randomized controlled clinical trials
- 25 January 2023
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (680), eadg2970
- https://doi.org/10.1126/scitranslmed.adg2970
Abstract
Adequate and well-controlled clinical trials remain critical tools for helping to bring benefit to patients in medical need.Keywords
This publication has 7 references indexed in Scilit:
- Approval success rates of drug candidates based on target, action, modality, application, and their combinationsClinical and Translational Science, 2021
- Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiotaScientific Reports, 2019
- Randomised controlled trials – the gold standard for effectiveness researchBJOG: An International Journal of Obstetrics and Gynaecology, 2018
- Randomization—There Is No SubstituteJAMA Cardiology, 2016
- The Platform TrialJAMA, 2015
- Treating Clostridium difficile Infection With Fecal Microbiota TransplantationClinical Gastroenterology and Hepatology, 2011
- Clinical Trials and Medical Care: Defining the Therapeutic MisconceptionPLoS Medicine, 2007